Mesoblast Newsroom

JPMorgan Chase Takes Significant Stake in Mesoblast

TipRanksNov 20 16:52 ET

Mesoblast Announces Director Change and Shareholdings

TipRanksNov 18 07:19 ET

Mesoblast Limited's AGM Resolutions Gain Strong Approval

TipRanksNov 15 01:28 ET

Mesoblast Director Joseph Swedish Steps Down

TipRanksNov 15 01:27 ET

Mesoblast Limited Outlines Future Strategies and Growth Prospects

TipRanksNov 14 20:09 ET

Mesoblast Limited Issues Unquoted Warrants in Strategic Move

TipRanksNov 12 04:18 ET

Maxim Group Maintains Mesoblast(MESO.US) With Buy Rating, Raises Target Price to $18

Moomoo NewsNov 6 08:37 ET · Ratings

Buy Rating for Mesoblast Driven by Promising Market Opportunities and Upcoming PDUFA Date for Ryoncil

TipRanksNov 6 07:45 ET · Ratings

Express News | Mesoblast Ltd : Maxim Group Raises Target Price to $18 From $12

ReutersNov 5 07:41 ET

Mesoblast Posts Cash Balance of Over $51 Million in Fiscal Q1

MT NewswiresOct 31 21:16 ET

Piper Sandler Maintains Mesoblast(MESO.US) With Buy Rating, Maintains Target Price $11

Moomoo NewsOct 31 07:31 ET · Ratings

Press Release: Appendix 4C Quarterly Activity Report for Quarter Ended September 30, 2024

Dow JonesOct 30 19:11 ET

When Will Mesoblast Limited (ASX:MSB) Become Profitable?

Yahoo FinanceOct 30 16:34 ET

Mesoblast Management to Meet With Maxim

TipRanksOct 21 14:23 ET

Mesoblast Advances Cellular Medicines Amid FDA Hopes

TipRanksOct 18 06:30 ET

6-K: Report of foreign private issuer (related to financial reporting)

SECOct 18 06:04 ET · Announcements

Mesoblast Limited Schedules 2024 Annual General Meeting

TipRanksOct 16 23:27 ET

Mesoblast Limited Enhances Corporate Governance Transparency

TipRanksOct 16 23:17 ET

Fastenal Posts Upbeat Earnings, Joins Wells Fargo, JPMorgan And Other Big Stocks Moving Higher On Friday

BenzingaOct 11 10:28 ET

Mesoblast Shareholding Structure Altered

TipRanksOct 9 22:47 ET